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Abstract 
 
In this project, we have developed a novel platform for capturing, transport, and separating target analytes 
using the work harnessed from biomolecular transport systems. Nanoharvesters were constructed by co-
organizing kinesin motor proteins and antibodies on a nanocrystal quantum dot (nQD) scaffold. 
Attachment of kinesin and antibodies to the nQD was achieved through biotin-streptavidin non-covalent 
bonds. Assembly of the nanoharvesters was characterized using a modified enzyme-linked 
immunosorbent assay (ELISA) that confirmed attachment of both proteins. Nanoharvesters selective 
against tumor necrosis factor-α (TNF-α) and nuclear transcription factor-κB (NF-κB) were capable of 
detecting target antigens at <100 ng/mL in ELISAs. A motility-based assay was subsequently developed 
using an antibody-sandwich approach in which the target antigen (TNF-α) formed a sandwich with the 
red-emitting nanoharvester and green-emitting detection nQD. In this format, successful sandwich 
formation resulted in a yellow emission associated with surface-bound microtubules. Step-wise analysis 
of sandwich formation suggested that the motility function of the kinesin motors was not adversely 
affected by either antigen capture or the subsequent binding of the detection nQDs. TNF-α was detected 
as low as ~1.5 ng/mL TNF-α, with 5.2% of the nanoharvesters successfully capturing the target analyte 
and detection nQDs. Overall, these results demonstrate the ability to capture target protein analytes in 
vitro using the kinesin-based nanoharvesters in nanofluidic environments. This system has direct 
relevance for lab-on-a-chip applications where pressure-driven or electrokinetic movement of fluids is 
impractical, and offers potential application for in vivo capture of rare proteins within the cytoplasmic 
domain of live cells. 
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1.0 Introduction 
Efficient transport of macromolecules within the cytoplasm is crucial to a wide range of cellular functions. The 
high viscosity environment limits the efficacy of diffusional transport, particularly at longer length scales such as in 
the axons of neurons (e.g., up to a meter in length).1 Thus, living systems have developed a complex set of energy-
consuming transport systems to achieve directed, high-efficiency transport of macromolecules within cells. These 
active transport systems involve specialized classes of enzymes known as motor proteins and associated cytoskeletal 
filaments.2-4 For example, the motor proteins kinesin and dynein move along microtubule filaments, enabling the bi-
directional transport of macromolecules, including vesicles, over considerable distances.5 Such efficient transport 
systems provide useful models for understanding and engineering analogous systems in artificial nanoscale 
environments. 
The different members of the kinesin superfamily of motor 
proteins are considerably diverse, but share certain conserved 
structural motifs: a motor domain, neck-linker domain, and often a 
coiled-coil tail domain (Figure 1). The motor domain of all kinesin 
consists of an ATP-catalytic side and a microtubule binding site.6,7 The 
neck-linker domain serves as a mechanical transducer, enabling the 
conformational changes in protein structure needed for movement. 8-10 
The coiled-coil tail domain, coupled with associated light chains, is 
responsible for cargo binding.11,12 Kinesin-based transport rates of ~12 
µm/sec and catalytic efficiencies (i.e., conversion of chemical energy 
into work) of ~50% have been reported.13-15 All kinesin motors move 
along microtubules, which are hollow protein polymeric filaments with 
a diameter of ~25 nm and tens of microns in length. Microtubule 
assembly occurs through the GTP-driven polymerization of αβ tubulin 
dimers into protofilaments,16 which subsequently assemble into a 
hollow cylinder. In cells, microtubules often polymerize from a central 
structure known as a centrosome, and form a three-dimensional transportation network within the cell.1,17 Together, 
kinesin and microtubules provide a high-efficiency system for transporting macromolecular cargo through the 
cytoplasm of a cell. 
The intriguing and powerful properties of active transport systems have spurred their application in hybrid 
nanoscale systems.18-21 Early work in this area was focused on applying microfabrication technologies to guide the 
kinesin-based transport of molecular shuttles (i.e., stabilized microtubule filaments) and achieve directed transport 
of materials at the nanoscale.22-27 In this system, known as the gliding motility geometry, kinesin motor proteins are 
bound on a solid surface such that their catalytic and microtubule-binding domains extend into the solution. In the 
presence of ATP, microtubule filaments bind to the kinesin, and guide across the surface in a highly stochastic 
manner.20 As mechanisms for guiding transport emerged, work began focusing on methods of cargo attachment to 
molecular shuttles, and the development of simple devices and materials. The kinesin-based transport of a wide 
range of synthetic (e.g., metallic, semiconductor, and polymer nanoparticles)28-32 and biological (e.g., protein, 
viruses, DNA, etc.)33-39 materials on molecular shuttles has been demonstrated. More recently, the assembly of 
photonic nanocomposites has been achieved,40 marking the first successful nanoscale application of kinesin 
transport for practical use. 
The ability to transport biological materials in vitro using the kinesin-microtubule transport system also 
provides technological insight for manipulating active transport within living cells. In vivo control of active transport 
could potentially be used for studying a wide range of physiological phenomena such as axonal transport, mitotic 
spindle formation, chromosomal segregation, and melanophore dynamics. The central question is: can intracellular 
active transport systems be exploited or manipulated for specific needs? Nature has provided model systems in 
which pathogenic organisms have evolved the ability to “hijack” the host cell’s active transport systems. For 
example, viruses co-opt active transport to move back and forth between the cell membrane and site of replication; 
the exact nature of these interactions, however, is currently unknown.41-45 Building from this concept, the primary 
goal of this project was to integrate principals of in vitro and in vivo kinesin-transport to develop a system that 
enables the harvest of rare target proteins inside individual live cells. A key application of this technology involves 
the ability to capture protein analytes within a cell where their relative concentrations are considerably higher than 
exist after common biochemical extraction procedures. In addition, the exploitation of energy-dissipating transport 
(i.e., kinesin) along the three-dimensional microtubule network provides a highly efficient mechanism for probing 
the cytoplasmic content of a cell.  
 
Figure 1. Three-dimensional crystal 
structure of a conventional kinesin 
motor protein showing the location of 
the various conserved domains. 
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2.0 Materials & Methods 
2.1  Kinesin construction 
A histidine-tagged (His-tag), biotinylated kinesin was developed based on the K401-bio plasmid, which 
contains the first 410 amino acids of a conventional kinesin from Drosophila melanogaster and the biotin-carboxyl 
carrier proteins (BCCP) immediately downstream. The base plasmid (K401-bio) was generously provided by Dr. 
Jeff Gelles at Brandeis University. Two oligomers were commercially synthesized to introduce the 10x His-tag 
(sequenced underlined) into the K401-bio plasmid: 
His-For:  5’-AATTCGACGAACCGCTTGTTGTTATCGAACACCATCACCATCACCATCACCATCACCATTAAA-3’  
His-Rev: 5’-TTTAATGGTGATGGTGATGGTGATGGTGATGGTGTTCGATAACAACAAGCGGTTCGTCGAATT-3’                                      
The K401-bio plasmid was double digested with EcoRI and HindIII restriction endonucleases to create sticky ends 
for ligation of the oligomers. The digested plasmid was separated on an agarose gel, and a corresponding 3880-bp 
DNA bands was excised and column purified. The oligomers were then ligated into the digested plasmid using the 
ClonablesTM 2x Ligation Premix (Novagen, Inc.), and incubation at 16°C for 15 min. The resulting reaction was then 
transformed into NovaBlue competent cells (Novagen, Inc.), and plated on selective media and grown overnight at 
37°C. Several colonies were selected, and plasmid DNA was isolated and sent for sequencing to confirm successful 
insertion of the 10x His-tag. Once confirmed, the plasmid was transferred and expressed in Escherichia coli 
BL21(DE3)pLysS competent cells (Stratagene Corp.) as previously described.46 The recombinant K401-bio-His 
motors were purified using Ni-NTA sepharose chromatography as previously described.28,46 Purified protein was 
confirmed by SDS-PAGE electrophoresis, and stored in small aliquots at -80°C until nanoharvester construction. 
2.2  Nanoharvester assembly and validation 
Nanoharvester construction 
“Nanohavesters” (Figure 2) were constructed 
using streptavidin-coated nanocrystal quantum dots 
(nQDs) as a scaffold for spatially co-organizing 
biotinylated kinesin (motor transport component) and 
biotinylated antibodies (analyte capture component). 
Qdot® 605 or 655 (Invitrogen Corp.) nQDs were used 
for constructing all nanoharvesters in these 
experiments. Each nQD possesses 5-10 streptavidin 
molecules on the surface, corresponding to 20-40 
available biotin-binding sites (assuming all are active 
and available).  
Nanoharvesters were assembled by preparing a 
solution containing 50 nM nQDs, 350 nM 
biotinylated kinesin, and 150 nM biotinylated 
antibody in BRB80 (80 mM PIPES pH 6.9, 1 mM 
MgCl2, 1mM EGTA) containing 1 mM ATP. Under these conditions, each nanoharvester should possess an average 
of seven kinesin motors and three antibodies per nQD. The ratios of motors and antibodies were varied to optimize 
function as described below. The nanoharvester solution was then incubated on rotator at room temperature for 30 – 
60 min. 
 
Figure 2. Nanoharvesters were constructed through 
attachment of biotinylated kinesin and antibodies on 
streptavidin-coated nanocrystal quantum dots (nQDs). 
Validating nanoharvester assembly 
A modified version of an enzyme-linked immunosorbent assays was used to confirm assembly of the 
nanoharvesters. The assay involved attachment of specific protein analytes to a microtiter plate, followed by 
introduction of the nanoharvesters. Once unbound nanoharvesters were removed, an enzyme-conjugated anti-kinesin 
antibody was added and used to detect the presence of the motors. Thus, a colorimetric change in the substrate 
would only be achieved if both the kinesin motors and antibodies were co-organized on the nQDs.  
Microtiter plates (Nunc MaxiSorp 96) were coated with varying concentrations of either tumor necrosis factor-α 
(TNF-α) or nuclear transcription factor-κB (NF-κB): 1000 µg/mL, 500 ng/mL, 100 ng/mL, 10 ng/mL, 1ng/mL, 100 
pg/mL, and 0 ng/mL (control). All TNF-α and NF-κB solutions were prepared in bicarbonate/carbonate coating 
buffer pH 9.6, and incubated at 37°C for 3 hr. Plates were then washed twice with PBST (PBS+ 0.05% Tween-20)  
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for 3 min each, and blocked for 1 hr at room temperature with PBST containing 1% BSA. Nanohavesters selective 
against either TNF-α or NF-κB were then added to the plates, and incubated overnight at 4°C. Plates were then 
washed three times with PBST for 3 min each, followed by the addition of an alkaline phosphatase-conjugated anti-
kinesin antibody. Following a 3 hr incubation at 37°C, plates were washed three times with PBST, and the substrate 
(PNPP) was added to each well. The absorbance at 405 nm of each well was measured at 60 and 90 min after 
substrate addition. 
2.3  Optimizing nanoharvesters properties 
Optimization of the nanoharvesters involved varying the number of kinesin motors and antibodies per nQD to 
achieve maximum motor function and antigen capture, respectively. The number of motors necessary to achieve 
optimal transport of nQDs was determined for each lot of purified biotinylated kinesin and different size nQDs (e.g., 
Qdot® 605 and 655). Kinesin-based transport was evaluated using the normal motility assay,47,48 in which kinesin 
motors move along taxol-stabilized microtubules that are bound to functionalized glass surfaces. Fluorescence 
microtubules were polymerized at 37°C for 20 min using a mixture of unlabeled and rhodamine-labeled tubulin 
prepared in GPEM (80 mM PIPES pH 6.9, 1 mM MgCl2, 1mM EGTA, 100 mM GTP, and 5% glycerol). 
Microtubules were then stabilized by diluting 100-fold into BRB80T (BRB80 with 10 μM paclitaxel). Coverslips 
were prepared using 25 x 25 mm cover glass slips (VWR) cleaned by UV ozone for 20 minutes, and then 
functionalized with APDEMS (aminopropylsilanetriol 22-25% in water) and baked at 100°C for 20 min in a vacuum 
chamber. Standard flow cells were then assembled with the APDEMS coverslips, glass slides and double-sided tape. 
Polymerized microtubules were diluted in BRB12T (12 mM PIPES pH 6.9, 1 mM MgCl2, 1mM EGTA, and 10µM 
Taxol) supplemented with 0.2 mg/mL casein, 1mM ATP and an oxygen-scavenging system (0.008 mg/mL catalase, 
0.02 mg/mL glucose oxidase, 20 mM D-glucose, and 1 mM DTT). The microtubules were introduced to the flow 
cell and incubated for 10 min at room temperature. The flow cell was then blocked with BRB12CAT (BRB12T, 1 
mM ATP, and 5 mg/mL casein) for 10 min. Kinesin-coated nQDs were prepared as described above for the 
nanoharvesters. For initial optimization of kinesin motors, no antibodies were used in nanoharvester assembly and 
the number of kinesin per nQD was systematically varied from 1 – 10 motors. The number of antibodies was then 
systematically varied from 0 – 10 antibodies per nQD to optimize nanoharvesters function. Kinesin-nQDs or 
complete nanoharvesters were introduced to the flow, incubated for 5 min, and then characterized using fluorescence 
microscopy. Time-lapse images of kinesin-nQDs were collected, and processed using Olympus Microsuite software. 
The velocity, binding, and percent nQDs moving were evaluated for each treatment. 
2.4  In vitro capture and detection 
In vitro capture and detection of 
TNF-α by nanoharvesters was 
performed using the normal motility 
as described above. Flow cells were 
constructed using APDEMS-coated 
coverslips, rhodamine microtubules 
were bound to the surface, and flow 
cells were blocked with BRB12 with 5 
mg/mL casein. Nanoharvesters were 
constructed with seven kinesin motors 
and three antibodies per nQD 
(Qdot®655) in BRB12CAT (BRB12 
with 0.2 mg/mL casein, 1 mM ATP 
and 10 µM paclitaxel), and stored at 
4°C. TNF-α was then added to a final 
concentration of 165 ng/mL, and 
incubated at 4°C. Secondary, 
detection nQDs (streptavidin-coated 
Qdot®525) were assembled in a 
solution containing 2.5 nM nQDs, and 
75 nM biotinylated anti-TNF-α in BRB12CAT. The secondary nQDs were incubated for 5 – 10 min at 4°C, and then 
added to the reaction containing the nanoharvesters and antigen. An antibody “sandwich” between the two nQDs 
(A) (B)
 
Figure 3. (A) The in vitro capture and detection assay involved the 
formation of a “sandwich” between the nanoharvesters (red nQD) and a 
detection nQD (green) only in the presence of the target analyte. (B) 
Movement of the sandwiched nQDs was detected by yellow fluorescence 
(combined red and green emission) along microtubule filaments bound to 
a surface.
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(red and green) should form only in the presence of the antigen, as shown in Figure 3A. Following incubation, the 
complete mixture was added to the flow cell and characterized by fluorescence microscopy. The presence of yellow 
fluorescence (combined red and green) indicated the successful capture of TNF-α (Figure 3B). Time-lapse images of 
kinesin-nQDs were collected, and processed using Olympus Microsuite software. The velocity, binding, and percent 
nQDs moving were evaluated for each treatment. To evaluate the sensitivity of TNF-α detection, nanoharvesters 
were exposed to varying dilution of antigen: 0, 1.65, 16.5, 82.5, 165, and 205 ng/mL. Time-lapse images were 
collected, and analyzed as described above. 
3.0 Results and Discussion 
3.1 Biotinylated, His-tag kinesin construction 
A 10x His tag was inserted at the C-terminus 
of the biotin carboxyl carrier protein domain 
(BCCP) in order to facilitate purification of the 
K401-bio kinesin motor protein (Figure 4). DNA 
sequencing confirmed insertion of the 10x His tag 
into the plasmid. The confirmed plasmid was 
transformed and expressed in E. coli BL21(DE3) 
pLysS, and the recombinant K401-bio-His 
kinesin was purified by Ni-NTA affinity 
chromatography. Because a portion of the BCCP 
gene was removed during insertion of the His tag, 
the level of biotinylation was measured to ensure 
that the protein was efficiently labeled. The level 
of kinesin biotinylation was >70% for all 
preparations used for nanoharvester assembly. 
Based on the results from the normal motility 
assays, the recombinant kinesin was active for 2 – 
3 weeks when stored at -80C.  
BCCP-His-Drosp Kin
3943 bp
DKHC
BCCP
His-tag
K401-BCCP-His
AmpR (bla)
T7 promoter
ApaLI (3605)
ApaLI (486)
ApaLI (3097)
ClaI (1516)
EcoRI (1446)
HindIII (1509)
NcoI (1213)
Pst I (886)
ApaLI (2326)
 
Figure 4. Plasmid map of the constructed K401-bio-His 
kinesin motor protein. 
3.2  Assembly and optimization of nanoharvesters  
The ELISA-based assays demonstrated successful assembly of nanoharvesters selective against both TNF-α and 
NF-κB (Figure 5). For both analytes, the absorbance at 405 nm followed an exponential rise to a maximum across 
the concentration range tested, as expected in these assays. The absorbance was generally lower for NF-κB than 
TNF-α, which may be due to the efficacy of antibody binding the nQDs. The anti-NF-κB antibody was biotinylated 
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Figure 5. Results from ELISA-based assays confirming the successful assembly of nanoharvesters selective against 
TNF-α (A) and NF-κB (B). Values are mean ± standard error of the mean. 
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in our lab, whereas the anti-TNF-α antibody was purchased already biotinylated. Thus, the level of biotinylation of 
the anti-NF-κB may have been lower, resulting in less attachment to the nanoharvesters. The sensitivity of detecting 
both analytes was between 10 and 100 ng/mL in these assays. Overall, these ELISAs demonstrate successful 
assembly of the nanoharvesters. 
The functional properties of the nanoharvesters 
were optimized by first varying the density of 
kinesin motors as a function of the different 
quantum dots. The number of motors required per 
nQD to achieve quantum dot movement increased 
linearly based on the size of the quantum dot 
(Figure 6A), while the velocity and binding of 
nQDs per field of view showed little size 
dependency. The independent relationship between 
motor density and velocity/binding of kinesin-
coated polymer beads has previously been 
demonstrated.49 The values from the three 
measured parameters were averaged (equal weight 
for each parameter) to determine the conditions for 
optimal function (Figure 6B). Overall, the optimal 
number of kinesin motors per nQD displayed a 
linear relationship to the nQD peak emission, 
which directly correlates with size.  
Nanoharvesters were then optimized with 
respect to the ratio of kinesin motors and 
antibodies per nQD. The effect of antibody-
coupling to the kinesin-coated nQD (i.e., the 
complete nanoharvesters) was then evaluated by 
varying the ratio from 0 – 10 (10:0, 10:3, 10:5, and 
10:9) antibodies per nQD. The binding of 
nanoharvesters per field of view was similar at the 
ratios of 10:0, 10:5, and 10:9, but significantly 
lower for the 10:3 ratio of kinesin to antibodies 
(Figure 7A). This observed difference was 
attributed to less non-specific binding of 
nanoharvesters to the APDEMS surface. The 
velocity of the nanoharvesters was significantly 
affected only at the 10:9 ratio of kinesin to 
antibodies (Figure 7B), which is likely due to either 
steric crowding of the kinesin motors by the 
antibodies, or competition for available 
streptavidin sites.  The velocity observed at the 
other ratios was ~0.5 μm/sec, which is consistent 
with previous reports.47,48,50 The percentage of 
functional nanoharvesters was greatest at the 10:3 
ratio, and lowest at the 10:9 ratio (Figure 7C).  
Based on these data, the three antibodies per nQD 
was selected as the optimal conditions for 
nanoharvester functionality.  
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Figure 6.  (A) The number of kinesin motors per nQD 
required to attain maximum quantum dot movement (i.e., 
% quantum dots moving per field of view), velocity, and 
binding per field of view for Qdot® 525 (black bar), Qdot® 
605 (light gray bar), and Qdot® 655 (dark bar). (B) The 
numbers of motors per nQD for each treatment were 
averaged (equal weight to each parameter) to provide an 
estimate for the optimal conditions for each size nQD. The 
data followed an approximate linear relationship. Values 
are mean ± standard error of the mean. 
3.3  In vitro capture and detection  
The ability of kinesin nanoharvester to capture, transport, and detect target analytes in vitro was evaluated using 
a sandwich-based approach in the normal motility assay. In this approach, the target antigen is captured by the 
nanoharvesters (red nQD), and forms a sandwich with a detection (green) nQD (Figure 3A). The co-localization of 
red- and green-emitting nQDs in the sandwich results in a yellow fluorescence signal that moves along microtubules 
in the normal motility assay.   
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The ability of the nanohavesters to capture and 
transport TNF-α was initially evaluated in a step-
wise manner. Nanohavesters were assembled using 
red quantum dots (e.g., Qdot® 655) and a 
monoclonal antibody selective against TNF-α, as 
described above. Secondary, green nQDs coated 
with polyclonal anti-TNF-α antibody were 
prepared as described above. Three separate 
treatments, representing each step in the sandwich 
formation, were prepared: (1) nanoharvesters 
alone, (2) nanoharvesters with 165 ng/mL TNF-α, 
and (3) nanohavesters with 165 ng/mL TNF-α and 
secondary detection nQDs. Each treatment was 
introduced to separate flow cells, incubated for 10 
min, and imaged by fluorescence microscopy. 
Nanoharvesters were able to successfully 
capture and transport TNF-α in motility assays 
(Figure 8). Yellow fluorescence from nano-
harvester sandwiches was observed to move along 
microtubules; blinking of the nQDs also confirmed 
the co-localization of the two nQDs. The average 
velocity over all treatments was ~0.40 ± 0.02 
µm/sec, and did not significantly vary based on 
treatment (P = 0.129; Figure 9). The percent 
movement of nanoharvesters did, however, vary 
significantly based on the different treatments (P < 
0.001; Figure 9). The percent nanoharvester 
movement in the complete sandwich assay was 
significantly lower than the nano-harvesters alone. 
This observation may be due to non-specific 
binding of the detection nQDs either to the 
microtubules or the APDEMS-coated surface. A 
significant percentage (~8%) of nano-harvesters 
with captured analyte and secondary nQDs moved 
in each field of view. In addition, isolated instances 
(<1%) of green nQDs (not coupled to red nQDs) 
moving along microtubules was observed, 
suggesting that free biotinylated kinesin motors 
were capable of binding to open streptavidin sites 
on the green nQDs. While such events did not 
affect the assay, covalent coupling of antibodies to 
detection nQDs represents a potential route for 
eliminating the unintended binding of motors to 
detection nQDs. 
The sensitivity and selectivity of the 
nanoharvesters was next tested using a dilution 
series of TNF-α (0 – 205 ng/mL. Approximately 
5% of the nanoharvesters per field of view (FOV), 
as detected by the binding of a green detection 
nQD, successfully captured TNF-α antigen across 
all concentrations of TNF-α evaluated. The level of 
detection as a function of TNF-α concentration was 
non-linear, and varied significantly based on 
concentration (P < 0.001; Figure 10A). Non-
specific sandwich formation (2.4 ± 0.4%) was 
observed in the absence of TNF-α, and likely due 
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Figure 7.  The binding of nanoharvesters per field of view 
(A), velocity (B), and percentage of functional 
nanoharvesters (C) for the varying ratios of kinesin to 
antibodies. Dotted lines were added to help visualize 
trends in each parameter as a function of increasing 
numbers of antibodies per nQD. Bars are mean ± standard 
error of the mean. 
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Figure 8. Time-lapse photomicrographs showing the capture and transport of TNF-α by kinesin nanoharvesters. 
Yellow fluorescence is observed when a “sandwich” is formed by antibody-functionalized red and green nQDs 
bound together in the presence of TNF-α. Blinking of the nQDs over time can be observed and enables the s
of each nQD to be confirmed. Yellow arrows are used to mark movement of harvester between frames. Images
represent 5 sec intervals. Scale bar = 2 µm. 
ignal 
 
to the cross-reactivity of the two streptavidin-coated nQDs with biotinylated antibodies. As discussed above, 
covalent linking of antibodies to the detection nQD may alleviate this issue. The percentages of nanoharvesters with 
captures for all TNF-α concentration were significantly greater than the level of non-specific binding (P <0.001), 
suggesting that the sensitivity of detection was at ~1.65 ng/mL (P = 0.006; comparison with negative control). The 
greatest level of detection (11%) was observed at the 16.5 ng/mL concentration of TNF-α, and decreased at the 
higher concentrations. This decrease is likely a result of competition between TNF-α bound to the nanoharvesters 
and in free solution for antibody sites on the detection nQDs. At high concentrations, free TNF-α can bind directly 
to the detection nQD and limit binding to the TNF-α bound to the nanoharvesters. This issue (i.e., analyte 
competition) should be carefully considered when designing in vitro diagnostic systems in order to maximize 
detection across a broad range of analyte concentrations. Removal of unbound analytes prior to introduction of the 
detection nQDs represents one potential mechanism to alleviate competition and optimize detection.  
The mean velocity of nanoharvesters with captures (i.e., antigen and detection nQDs) was 0.28 ± 0.03 μm/sec, 
and varied significantly across the different concentrations (Figure 10B; P = 0.02). The velocity of nanoharvesters 
with captures at the 16.5 (0.37 ± 0.05 μm/sec) and 82.5 (0.41 ± 0.09 μm/sec) ng/mL concentrations were similar to 
those observed in initial assays (Figure 8). A significant decrease in velocity, however, was observed at the 1.65 
ng/mL concentration of TNF-α, but within the normal range expected.48,50 Together these data suggest that kinesin-
based transport was not adversely affected by the capture of TNF-α or presence of detection nQDs. Thus, the 
sandwich approach may be successfully applied to lab-on-a-chip applications in which kinesin transport is used to 
capture and separate target analytes from a mixed solution. 
The percentage of moving nanoharvesters with captures (i.e., antigen and detection nQDs) was 18 ± 1.6%, and 
did not vary across the different TNF-α concentrations (P = 0.545; Figure 10C). Overall, the percentage of 
nanoharvesters with captures moving was 
similar, within experimental variation, to 
that observed in the step-wise evaluation 
of nanoharvester movement (Figure 9).  
Overall, these experiments 
demonstrate the successful development 
of an in vitro diagnostic assay using 
kinesin-based nanoharvesters. The 
primary advantage of this technology 
involves the application of nanoscale, 
biomolecular transport to actively shuttle 
captured analytes within the confines of a 
device. This system offers a unique 
paradigm in which analytes are moved 
within a static medium. Such a system 
removes the need for mechanical 
pumping or electrokinetic-driven flow of 
analytes for diagnostic analysis. Rather, 
the conversion of chemical energy into 
mechanical work by kinesin motors 
proteins is used to actively capture, 
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Figure 9. Transport velocity (white bars) and percent movement 
(gray bars) of nanohavesters alone, nanoharvesters with TNF-α, 
and the complete sandwich assay (i.e., nanoharvesters with TNF-
α, and secondary detection nQDs). Bars are mean ± standard error 
of the mean. 
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`transport, and separate target analytes 
within a solution. The efficiency of the 
chemo-mechanical conversion is ~50%, and 
makes it an attractive means of 
accomplishing nanofluidic transport in lab-
on-a-chip devices. 
4.0 Conclusions 
We have demonstrated the ability to 
apply biomolecular transport for the in vitro 
capture and transport of target analytes. In 
contrast to previous work,33,39 this system 
uses nQDs co-functionalized with kinesin 
and antibodies (i.e., nanoharvester) to 
capture and transport protein analytes in the 
normal motility geometry. Assembly of 
nanoharvesters selective against TNF-α and 
NF-κB was confirmed using an ELISA-
based method, and demonstrates the ability 
to assemble nanoharvesters against a range 
of target analytes. Detection of captured 
analytes in motility assays was 
accomplished using a secondary nQD with 
a different spectral emission to form an 
antibody-based sandwich. TNF-α was 
successfully detected at levels as low as 
1.65 ng/mL, and did not adversely affect 
the motility function of the kinesin motors. 
Overall this system offers tremendous 
applications in lab-on-a-chip applications 
based on the ability to harness useful work 
from the biomolecular conversion of 
chemical energy into mechanical work. 
This work can be used to actively capture, 
transport, and separate target analytes in the 
absence of pressure-driven or electrokinetic 
flow. This system may also be adapted for 
in vivo capture of analytes within the 
cytoplasm of a cell. The ability of kinesin-
coated nQDs to move along the 
microtubule networks of live cells has 
previously been demonstrated.50 By 
applying a similar strategy, kinesin-based 
nanoharvesters may be introduced into live 
cells and used to capture analytes within the 
confines of a cell where the effective 
concentration of analytes is much greater 
than following traditional extraction 
procedures. If successful, nanoharvesters 
may be used to capture rare target proteins 
within cells, and study physiological 
phenomena such as innate immunity in a 
manner not achievable by current methods. 
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Figure 10.  The percent of nanoharvesters with captures per field of 
view (A), velocity of nanohavesters with captures (B), and percent 
of captures moving (C) as a function of TNF-α concentration. 
Dotted lines were added to help visualize trends over the different 
concentrations. Bars are mean ± standard error of the mean. 
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